Latest Europe News

Arafura Rare Earths launches a two-tranche A$350 million placement and a A$25 million share purchase plan, closing the equity funding gap for its Nolans Rare Earths Project ahead of construction.

Little Green Pharma (ASX:LGP) posted a 15.3% revenue increase to AUD 42.5 million in FY2026, driven by European market expansion, yet recorded a $1.4 million loss after tax impacted by significant inventory write-downs.

ClearVue Technologies has secured a A$305,000 contract to supply over 800m² of building-integrated photovoltaic glazing for the Rio Business Centre redevelopment in Paphos, Cyprus, marking a tangible commercial step for its solar façade technology.

Eden Innovations appoints former European Parliament member Antanas Guoga to lead EdenShield’s push into European defence and critical infrastructure markets amid surging regional security spending.

AFT Pharmaceuticals posted a 22% revenue jump to NZ$254.7 million and a 39% increase in operating profit to a record NZ$24.4 million for FY26, exceeding guidance. The company targets over NZ$300 million revenue for FY27, fueled by international expansion and a deepening R&D pipeline.

Ballard Mining's March quarter update reveals a robust 1.2 million ounce gold resource at Mt Ida and a healthy $75.6 million cash position, setting the stage for a Final Investment Decision in H1 2027.

Everest Metals Corporation (ASX: EMC) has upgraded its Mt Edon Critical Minerals Project resource to 4.3 million tonnes at 0.23% Rb2O, enhancing grade, tonnage, and confidence ahead of a mining proposal submission expected to gain approval by late 2026.

James Hardie Industries saw a 25% sales increase in FY26 driven by the AZEK acquisition but reported a 75% net income decline amid acquisition costs and margin pressures. The company expects synergy gains and adjusted EBITDA growth in FY27.

Electro Optic Systems (ASX:EOS) has closed its three-year turnaround and is now poised for growth, backed by a landmark high-energy laser contract, a major European acquisition, and a $175 million capital raise.

4DMedical’s CT:VQ™ technology has been clinically validated in a top respiratory journal, showing a leap in patient response rates for lung volume reduction surgery from 46% to 76%, promising improved outcomes and hospital efficiencies.

Provaris Energy, alongside Kawasaki Kisen Kaisha (K LINE) and Norwegian Hydrogen, has formalised a cooperation to develop a commercial hydrogen shipping supply chain from Norway to Northern Europe, focusing on cost modelling and charter terms for compressed hydrogen transport.

Electro Optic Systems (ASX:EOS) has launched a A$175 million capital raising to complete its MARSS acquisition and accelerate expansion in counter-drone and defence technologies, buoyed by a surge in Middle East orders.